Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00895986 · ClinicalTrials.gov registry record · NA
Using Conversation Maps to Reinforce Self-Care
A NA study, sponsored by Joslin Diabetes Center.
- Completed
- Registry status
- NA
- Development phase
- 134
- Enrollment target
NCT00895986: Completed NA study, sponsored by Joslin Diabetes Center.
NCT00895986 is a NA study that has completed, run by Joslin Diabetes Center. The registered enrollment target is 134 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00895986, a NA study, has completed, sponsored by Joslin Diabetes Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 134 participants
- Enrollment target
Study Summary
Many people with type 2 diabetes are not able to keep their blood glucose in good control. Improving blood glucose control and maintaining that improvement is important for diabetes patients because doing so delays the onset and progression of severe complications of diabetes. Although educational programs may be helpful, their effect is not always long-lasting. This project is studying whether the Conversation Maps program (an interactive diabetes education program) reinforces diabetes education and information and thus helps type 2 diabetes patients take better care of their diabetes and blood glucose levels. Half of the patients will attend the Conversation Maps program and half of the patients will attend an educational program about blood pressure and cholesterol. Also, all patients will come in for 4 or 5 appointments to complete surveys and other tests and have their blood drawn. The group of patients who attend the Conversation Maps program will be compared to the group of patients who attend the blood pressure and cholesterol program to see if the educational programs helped diabetes patients to improve their diabetes control and quality of life and to maintain that improvement over time.
Interventions
- BEHAVIORAL Conversation Maps Diabetes Education
- BEHAVIORAL Heart Healthy Living Diabetes Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2008-12 |
| Est. Completion | 2012-03 |
| Phase | NA |
What the finished NCT00895986 record still lists
NCT00895986 is an interventional study that assigns participants to a tested intervention. The registered 134 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 2 interventions - of which Conversation Maps Diabetes Education is the first listed.
NCT00895986 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00895986 about?
NCT00895986 is a clinical study titled "Using Conversation Maps to Reinforce Self-Care". Many people with type 2 diabetes are not able to keep their blood glucose in good control. Improving blood glucose control and maintaining that improvement is important for diabetes patients because doing so delays the onset and progression of severe complications of diabetes. Although educational p...
What is the current status of trial NCT00895986?
This trial is currently completed. It is a NA study. The enrollment target is 134 participants. The study started on 2008-12. Estimated completion is 2012-03.
What interventions are being tested in trial NCT00895986?
The interventions under investigation include: Conversation Maps Diabetes Education (BEHAVIORAL), Heart Healthy Living Diabetes Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT00895986?
This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00895986's enrollment target sits among peer trials
134 728th of 2000 higher than 1,272 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02469662 · 134 participants · NA
Clinical Outcomes Study of the Nexel Total Elbow
- NCT03110822 · 134 participants · Phase 1
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
- NCT04678648 · 134 participants · Phase 1
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- NCT05264857 · 134 participants · NA
Decision Aid and Thyroid Nodules Management
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia